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ABSTRACT: 
Background: Cardiac resynchronization therapy (CRT) improves left ventricular (LV) 
function and induces LV remodeling, and it is an established therapy for advanced heart 
failure with prolonged QRS duration. One third of patients will not benefit from this invasive 
therapy.  
Objective: We sought to evaluate whether left atrial (LA) strain imaging (ε) parameters could 
help in predicting the response in terms of LV reverse remodeling after CRT. 
Methods: A total of 79 patients who underwent CRT were evaluated with echography before 
implantation. LA function and LV function were assessed with M-mode, two-dimensional 
echocardiography, Doppler, tissue Doppler velocity and ε. LV reverse remodeling was 
defined as a reduction in LV end-systolic volume of >15%.  
Results : At 6 months, 54 (68%) patients were responders to CRT. In multivariable logistic 
regression, LA systolic peak of strain rate (SRA) (OR = 10.5; 95% CI=1.76-62.1, p=0.01), left 
bundle branch block (OR=6.8, 95% CI = 1.06-43.9, p=0.04), ischemic cardiomyopathy 
(OR=3.93, 95% CI=1.07-14.4, p=0.04) and LV pre-ejection index (OR=1.03, 95% CI=1.01-
1.05, p=0.01) were associated with CRT response. With an SRA cut-off of -0.75%, the 
negative predictive value for predicting CRT response was 0.62. 
Conclusion: The present study demonstrated that it could be enormously relevant to assess 
LA function before CRT. SRA appeared to be a good predictor of CRT response. Integrating 
this LA function analysis into the multivariable assessment of patient candidates for CRT 
should be considered. 
 
Key words: cardiac resynchronization therapy, left atrial function, strain imaging, 
echocardiography  
 
List of the abbreviations: 
CRT: cardiac resynchronization therapy 
LA: left atrial 
LV: left ventricular 
EF: ejection fraction 
AV: atrio ventricular 
DFT: diastolic filling time 
V: volume 
LVPEI: LV pre-ejection interval 
IVMD: inter-ventricular mechanical delay 
 
Introduction  
Echocardiography plays an important role in patient assessment before cardiac 
resynchronization therapy (CRT), and it can monitor many of the mechanical effects of CRT 






. Encouraged by the highly variable individual response observed 
in the major CRT trials, echocardiography-based measurements of mechanical dyssynchrony 











. There has been no consensus on mechanical dyssynchrony analysis before CRT 






. According to the 
current literature, it seems that one can still hope to predict the response to CRT with 




Apart from mechanical dyssynchrony, other morphologic parameters have been tested to 
predict CRT response. Leyva et al
11
 considered left ventricle fibrosis assessed by cardiac 
magnetic resonance. Damy et al
12
 showed the prognostic value of right ventricle function.  





. Until now, diastolic function, with the exception of atrio-ventricular 
dyssynchrony
15
, has not been expected to be reported when assessing a patient before CRT 
implantation. Nevertheless, the value of LA volume as a strong prognostic marker has largely 
been demonstrated in many fields, including systolic heart failure
16
. Furthermore, we can 
easily assess the size of the LA, as well as its function to some extent. Very promising 
observations have been made in the field of CRT
17
, including a study performed in our 
institution
14
, and even more observations have been made in the field of valvular heart disease 
18
. Speckle tracking echocardiography is a novel method for angle-independent and objective 
quantification of myocardial deformation from standard bidimensional datasets; speckle 
tracking has the advantages of being angle-independent and being weakly affected by 
reverberations, side lobes and dropout artifacts. Speckle tracking echocardiography has 
recently evolved, and, by enabling the quantification of longitudinal myocardial LA-
deformation dynamics, it was recently proposed as an alternative approach for the estimation 
of LV filling pressure. In fact, the LA is exposed to the cumulative effects of filling pressures 
over time and could, therefore, provide a more sensitive and likely  more relevant expression 
of the severity of LV (and heart as a whole) dysfunction than measurement of the 
characteristics of the left ventricle. 
Therefore, we sought to examine the ability of LA function characteristics to predict response 
to treatment in a typical population of patients referred for CRT. 
 
Methods  
Patient population  
Between April 2007 and February 2012, consecutive patients scheduled to undergo 
implantation of CRT systems at the Rennes University medical center were prospectively 
included in this study. The goal was to assess the feasibility and value of using LA strain (as a 
relevant manner for assessing LA function), in terms of predicting LV-reverse remodeling. 
The inclusion criteria were: 1) New York Heart Association (NYHA) functional class II-IV, 
despite optimal medical therapy; 2) an LVEF ≤35%; 3) a stable sinus rhythm, 4) a QRS 
duration ≥120 ms on 12-lead electrocardiography; and 5) no previous pacemaker or 
cardioverter defibrillator implantation. Patients with atrial fibrillation were excluded. Heart 
disease was considered ischemic if a 50% stenosis was observed in ≥1 major epicardial 
coronary artery or if the patient had a history of myocardial infarction or prior coronary 
revascularization. The patients were followed up at 6 months after implantation of the device. 
No patients were lost to follow-up, and all of them returned to the laboratory to meet the 
requirements of the study.  
Responders were defined as having a ≥15 % decrease in left ventricular end-systolic volume 
at the 6-month follow-up, compared with baseline. This measurement was chosen because it 
was the endpoint chosen in most of the studies in this field 
19
. 
This study was performed in accordance with the principles outlined in the Declaration of 
Helsinki on research in human subjects and with the procedures of the Rennes University 
Hospital Medical Ethics Committee (usual care). The study was approved by a national 
review committee (no. CNIL 0507317b). The patients provided their informed consent. 
 
Transthoracic echocardiography  
Each patient was placed in the left lateral decubitus position and was assessed using 
echocardiography with either the Vivid 7 or Vivid e 9 ultrasound system (GE Medical 
Systems, Horten, Norway), equipped with 2.5-MHz transducers. LV volume and LA volume 
(LAV) were quantified according to the recommendations of the American Society of 
Echocardiography 
20
. LAVs were calculated using the apical 4- and 2-chamber area-length 
method, and they were subsequently indexed to body surface area (LAV index [LAVI]) as 
described earlier
21
. Trans-mitral flow (E wave and deceleration time) and mitral annular tissue 
Doppler (E′ and S′) velocities were measured. The Doppler value recorded was the mean of 
three beats. All of the measurements were obtained according to recommendations of 
chamber quantification
20
 and diastolic function assessment 
22
. Diastolic filling time (DFT)/RR 
interval ratio was used to characterize atrioventricular (AV) dyssynchrony in the left heart. 
AV dyssynchrony was defined as DFT/RR <40%
15
. LV pre-ejection interval (LVPEI), and 





Left atrial deformation imaging indices 
Three consecutive cardiac cycles were recorded and averaged, and the frame rate was set to 
60 to 80 frames/sec. The analysis was performed offline using customized software 
(EchoPAC PC BT12; GE healthcare, Horten, Norway). The LA endocardial border was 
manually traced on the apical four-chamber view. After manual adjustment of a region of 
interest covering the full thickness of the myocardium, the software divided the left atrium 
into six segments and automatically scored the segmental tracking quality. The software 
rejected segments with inadequate image quality and excluded them from the analysis. 
Longitudinal strain curves were generated for each of the 6 LA segments in the four 
chambers. Global peak LA longitudinal strain during ventricular systole (εs) was then 
measured by averaging the values obtained from the 6 LA segments. The same tracing 
method was used to calculate the strain rate and to analyze the LA systolic peak of strain rate 
(SRA) 
23
. A cardiologist with a level 3 in echocardiography, who was unaware of the patients' 
information, analyzed all of the echocardiographic values (figure 1). 
Observer variability 
Twenty studies were randomly selected for inter-observer and intra-observer variability. 
Systolic strain and the strain rate from the left atrium apical four-chamber view were re-
measured by the same observer and by a second independent observer based on the digital 
data, using an offline system. 
 
Statistical analysis 
Continuous variables are presented as means (SDs) or medians (IQRs) in cases of skewness. 
Categorical data are summarized as frequencies and percentages. Differences in baseline 
characteristics between the two groups (responders and non-responders) were analyzed with 
Student’s t-test, the Mann-Whitney test, the Chi-square test or Fisher’s exact test, as 
appropriate. Correlations between variables were determined with Pearson’s product moment 
correlation analysis. Multivariate logistic regression analysis was used to assess relationships 
between the different variables and CRT response. We included in the multivariable analysis 
all of the variables with p < 0.05 in univariate analysis, after removing correlated variables 
(Pearson’s coefficient > 0.70). Stepwise forward/backward selection was performed according 
to the Akaike Information Criterion. Optimal cut-off values of LA parameters to predict 
response to CRT were determined by ROC curve analysis. The optimal cut-off value was 
defined as that providing maximal accuracy to distinguish between responders and non-
responders. A p value < 0.05 was considered statistically significant. 
 All of the statistical analyses were performed with the software package R (R Foundation for 





Study population and Clinical Status 
A total of 79 patients, of 102 consecutive patients (77%), were considered based on the 
recordings of their echocardiography, providing images allowing for the measurement of εs 
and SR-A. Their baseline demographic, clinical, echocardiographic characteristics are 
presented in table 1. The disease etiology was ischemic in 25% of the patients. More than 
90% of patients were treated with a beta-adrenergic blocker and an angiotensin-converting 
enzyme inhibitor or angiotensin II receptor blocker at the highest tolerated doses. At 6 
months, 68 % of the patients were responders to CRT.  
 
Measurement of Reproducibility 
For εs, the ICCs were 0.96 and 0.90, respectively, for inter- and intra-observer agreement, and 
for SRA, the ICCs were 0.83 and 0.78, respectively. The measurements of εs and SRA showed 
good reproducibility, with intra-observer and inter-observer variations similar to those 




Uni and multi-variable analysis 
The differences between basal clinical and echocardiographic parameters for the population 
and according to CRT response are shown in table 1. All of the parameters with a p < 0.05 in 
univariate logistic regression were entered into a multivariable logistic regression analysis. εs 
and SRA were strongly correlated (Pearson’s r = 0.81) and could not be analyzed together, so 
two multivariate logistic regression analyses were performed. The results are shown in table 
3. In multivariate analysis, the following were associated with CRT response: SRA (OR = 4.7, 
p = 0.02), LBBB (OR = 4.5, p = 0.05), non-ischemic cardiomyopathy (OR = 3.73, p = 0.04), 
LVPEI (OR = 1.02, p = 0.014) and εs (OR=1.12, p=0.04). 
 ROC analysis 
The ROC for SRA is shown in Figure 2 
. Table 4 shows the accuracy of testing according to different cut-off value. The best accuracy 
(0.77) was obtained with an SRA value of -0.75%. The best negative predictive value (NPV) 
was 0.62 in our population (64% of responders) and was obtained with an SRA value of -
0.75%. The best Predictive Positive Value (PPV) in our population is 0.89 and was obtained 
with a SRA value of -1%. Regarding LVPEI, the best cut-off in our population was 125 ms 
(140 ms in the literature 
15
). With this value, the accuracy was 0.76, and the PPV and NPV 
were, respectively, 0.86 and 0.60. If we associated LVPEI > 125 ms with SRA<0.75%, the 
PPV to predict CRT was 0.97, the NPV was then 0.53, and the accuracy was 0.72. 
Discussion  
The present study demonstrated that it could be quite relevant to assess LA function and, in 
particular, to consider LA strain data for predicting CRT response and non-response.  
LA has been proposed as being analogous in heart conditions to HbA1c in diabetes. . 
Nevertheless, very few investigations have been published that have examined the promising 
role of LA strain imaging in better understanding and perhaps in predicting the response or 
non-response to CRT. D’Andrea et al
13
 reported that LA strain could be measured in 
candidates for CRT. We previously observed significant reverse remodeling in LA functional, 
structural, and anatomic characteristics after successful CRT. LA reverse remodeling was 
correlated with baseline LA volume
14
. Yu et al 
17
 showed that responders to CRT had 
improvements in contraction velocity in both the left and right atria, as well as improvement 
in LA reverse remodeling with a reduction in the LA size. LA reverse remodeling was also 
more frequent in patients with LV reverse remodeling 
14
. 
The LA has multiple functions: it acts as a reservoir for blood during ventricular systole (atrial 
compliance), as a conduit for the passage of blood from the pulmonary veins to the left 
ventricle in early diastole (passive emptying) and as a contractile chamber to augment left 







been used as prognostic markers for adverse cardiovascular events in numerous clinical 
settings. 
Nevertheless, there is currently no accepted ‘gold standard’ for evaluating LA function, 
despite very promising studies. ε and SR techniques have enabled the evaluation of atrial 
function throughout the cardiac cycle, thereby facilitating the measurement of phasic atrial 
function. εS and SRA serve as measurements of LA compliance during the reservoir phase, 
with early diastolic SR a measurement of passive emptying during the conduit phase and late 
diastolic SR a measurement of active atrial contraction ()
23
. These parameters seem correlated 
with, or at least influenced by, atrial fibrosis. Kuppahaly et al 
26
 showed that there were 
correlations of LA fibrosis detected by delayed-enhancement MRI with LA ε and SR. Cameli 
et al 
27
 showed, in patients with severe MR, a close, negative correlation between measured εS 
and histological LA fibrosis grade. In a previous study, atrial fibrosis was strongly associated 
with prognosis in heart failure 
28
 . We could hypothesize that severe cardiomyopathy, with a 
fibrotic and not a deforming atrium, is not an adequate candidate for CRT. SRA and εS, as 
surrogate markers for atrial fibrosis, could help to define this group of cardiomyopathies, 
which would be too greatly remodeled to expect any reverse remodeling with any type of 
treatment. That remains a hypothesis and further prospective multi-center validation studies 
are required. The respective value of strain and strain rate is requiring the transfer of our 
monocentric observations to a prospective multicenter validation. 
Of course, LA function would have to be considered, in addition to other critical parameters. 
First, LBBB was a strong predictor of response to CRT in our study. The enrollment of 
patients occurred between 2010 and 2011, and the guidelines were more focused on QRS 
width than on QRS morphology, as they now are 
9
. This focus emphasized the importance of 
morphology over width. Ischemic cardiomyopathy has a lower response to CRT, as shown 
earlier 
19
. Additionally, the original goal of CRT was mitigation of mechanical dyssynchrony 
between the right and left ventricles, with a view toward improving hemodynamic function. 
Contraction of some segments might be so delayed that they end past the onset of ventricular 
filling and after the end of ejection, causing intra-ventricular asynchrony due to the 
coexistence of systole and diastole. LVPEI was used and validated to assess this mechanical 
dyssynchrony 
15
. In our study, in multivariable analysis, LVPEI was one of the parameters 
that predicted response to CRT. It is a simple index and one that has not been discredited in 
prospective trials 
1
. The present study focused on the value of LA function and particularly 
LA strain parameters for understanding the response to CRT. 
Limitations 
This was a mechanistic study that had as its only aim providing new knowledge about the 
mechanisms implicated in the response to CRT. We focused on the LA because LA strain and 
Ɛ  seemed perhaps more predictive of the response to CRT than the usual LV parameters that 
have been extensively studied previously. We must acknowledge that we only focused on the 
LA and not on the two atrial functions or on synchronicity. The far location of the atrium, the 
reduced signal-to-noise ratio, the thin atrial wall and the presence of the appendage and 
pulmonary veins make strain imaging of left atrium more difficult and time consuming than 
for the LV 
23
. Nevertheless, with dedicated attention (focusing on the atrium) and with the 
improvements in software proposed year after year, the application of speckle tracking in 
daily clinical routine is likely not a dream but almost a reality, provided its incremental value 
is confirmed in further studies. 
Conclusion 
The present study demonstrated that it could be  relevant to assess LA function before CRT. 
SRA appeared to be a good predictor of CRT response. Integrating this LA function analysis 
into the multivariable assessment of patients who are candidates for CRT should be 
considered. 
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Cardiac resynchronization therapy (CRT) improves left ventricular (LV) function and induces 
LV remodeling, and it is an established therapy for advanced heart failure with prolonged 
QRS duration. One third of patients will not benefit from this invasive therapy. The LA is 
exposed to the cumulative effects of filling pressures over time and could, therefore, provide a 
more sensitive and likely relevant expression of the severity of disease and of the risk of non-
response to a treatment supposed to reverse the remodeling. LA function could be robustly 
analyzed using speckle tracking and strain data. The present study demonstrated that it could 
be  relevant to assess LA function before CRT.  
  






CRT responders  
(n=54) 
p 
Men 54 (68.4%)  20 (80.0%)  34 (63.0)  0.97 
  Age (years old)  63.66 (10.59)  66.56 (10.17)  62.31 (10.60) 0.1 
Ischemic 
cardiomyopathy 
25 (31.6%)  15 (60.0%)  10 (18.5%)  <0.01 
Heart rate (beats/min)  66.51 (13.03)  64.72 (10.99)  67.33 (13.89) 0.41 
LBBB 66 (83.5%)  16 (64.0%)  50 (92.6%)  <0.01 
QRS (ms)  162.4 (20)  158.8 (30) 163.6 (27.5) 0.086 
NYHA (%):      0.70 
                     2  16 (23.2%)   5 (21.7%)   11 (23.9%)    
                     3 53 (76.8%)  18 (78.3%)  35 (76.1%)    
6 m WT (m)  414 (103)  423 (73.5) 414 (121.5) 0.68 
Septal flash 58 (73.4%)  13 (52.0%)  45 (83.3%)  <0.01 
LV EF    0.27 (0.10)    0.30 (0.12)   0.27 (0.9) 0.40 
GLS (%)   7.54 (2.58)   7.47 (3.13)   7.58 (2.31) 0.86 
LV ED diameter (mm)  67 (8)  69 (8)  66 (8) 0.1 
IV-delay (ms)  43 (24)  30 (19)  49 (24) 0.001 
LVPEI (ms) 136 (34) 117 (30) 145 (32) <0.001 
Ratio diastole/RR (%)   0.44 (0.11)   0.49 (0.09)   0.42 (0.11) 0.01 
Ratio E/A    0.89 (0.74)    1.29 (0.89)   0.76 (0.46) <0.01 
Ratio E/Ea   12.62 (6.56)   14.70 (8.07)  12.12 (5.82) 0.03 
LA Vi (ml)   41 (19)   46 (13)  38 (18) 0.04 
TAPSE (mm)  18 (4)  17 (3)  19 (4) 0.10 
SRA (s-1)   -1.00 (0.84)   -0.65 (0.35)  -1.19 (0.76) <0.001 
 εs (%)   13.10 (9.75)   10.30 (5.9)  14.60 (9.42) <0.01 
NT-ProBNP (pg/ml) 1238 (1882) 1993 (1447) 974 (1988) 0.08 
LBBB: Left Bundle Branch Block – 6m WT: 6 Minute Walking Test - LV EF: Left Ventricle Ejection 
Fraction – GLS: Global Longitudinal Strain – LA Vi: Left Atrium Volume Index – TAPSE: Tricuspid 
Annular Plane Systolic Excursion – SRA: LA Systolic Peak of Strain Rate – εs: LA global 
Longitudinal Strain 
  




Interobserver  Intraobserver 
Relative 
difference 




Εs  0.17 +/- 1.02 10.40% 0.98 (0.94 - 0.99)  -0.14 +/- 1.30 13.30% 0.95 (0.87 - 0.98) 
SRA   0.12 +/- 0.14 20.70% 0.83 (0.24 -0.95)  -0.005 +/- 0.12 16.50% 0.78 (0.33 - 0.92) 
COV: Coefficient of Variation – ICC: Intra-Class Coefficient – SRA: LA Systolic Peak of Strain Rate – εs: LA 
global Longitudinal Strain 
 
  






OR P OR p 
Male sex 0.42 (0.14 - 1.31) 0.14 0.74 (0.12 - 4.4) 0.74 
  Age (years old) 0.96 (0.92 - 1.01) 0.1 0.95 (0.87 - 1.02) 0.16 
Ischemic Cardiomyopathy 6.6 (2.3 - 18.9) 0.0005 3.73 (1.01 - 13.8) 0.04 
Heart Rate (beats/min) 1.02 (0.98 - 1.05) 0.41   
LBBB 7.03 (1.9 - 25.9) 0.003 4.5 (0.87 – 22.9) 0.05 
QRS (ms) 1.02 (0.99 - 1.05) 0.22   
NYHA (%): 0.61 (0.16 - 2.34) 0.47   
6 m WT (m) 1 (0.99 - 1.01) 0.92   
Septal Flash 4.62 (1.6 - 13.3) 0.005 2.1 (0.5 - 8.7) 0.31 
LV EF 0.06 (0.001 - 87.5) 0.45   
GLS (%) 1.02 (0.84 - 1.23) 0.86   
LV EDD (mm) 0.95 (0.90 - 1.01) 0.11   
IV-Delay (ms) 1.04 (1.01 - 1.07) 0.002   
LVPEI (ms) 1.03 (1.01 - 1.05) 0.001 1.02 (1.0 - 1.05) 0.04 
Ratio Diastole/RR (%) 0.0016 (0.001 - 0.243) 0.01 0.06 (0.001 - 23.5) 0.35 
Ratio E/A 0.67 (0.42 - 1.07) 0.09   
Ratio E/Ea 0.94 (0.87 - 1.01) 0.09   
LA Vi (ml) 0.98 (0.95 - 1.01) 0.20   
TAPSE (mm) 1.11 (0.97 - 1.27) 0.11   
SRA (s-1) 7.19 (2.14 - 24.1) 0.001 4.7 (1.26 - 17.8) 0.02 
 εs (%) 1.14 (1.04 - 1.26) 0.007 1.12 (1 - 1.24) 0.04* 
NT-ProBNP (pg/ml) 1 (1 - 1) 0.6   
LBBB: Left Bundle Branch Block – 6m WT: 6 Minute Walking Test - LV EF: Left Ventricle Ejection 
Fraction – GLS: Global Longitudinal Strain – LA Vi: Left Atrium Volume Index – TAPSE: Tricuspid 
Annular Plane Systolic Excursion – SRA: LA Systolic Peak of Strain Rate – εs: LA Global 
Longitudinal Strain 
*: This result came from a second multivariate model in which SRA and εs were correlated (r >0.7). 
 
  
Table 4: SRA and LVPEI Characteristics to Predict CRT Response 








SRA < -0.75% 0.80 0..2 0.86 0.62 0.77 
SRA < -1% 0.63 0.84 0.89 0.51 0.70 
LVPEI > 125 ms 0.78 0.72 0.86 0.60 0.76 
LVPEI >140 ms 0.56 0.80 0.86 0.46 0.63 
SRA< -0.75% & 
LVPEI > 125 ms 
0.61 0.96 0.97 0.53 0.72 
 
 
Figure 1: example of left atrial strain and strain rate acquisitions  
 
 
Figure 2: ROC Curve for LVPEI (Left) and SRA and Response to Cardiac Resynchronization 
Therapy at 6 Months 
